Want to join the conversation?
$AGN's products revenues jumped 112.8% to $3.51Bil. Botox revenue was $605MM for 3Q15 on continued strong performance in both aesthetic and therapeutic indications, and Restasis revenue was $328MM driven by continuing strong promotional efforts. Namenda XR revenue was $215MM as prescriptions and formulary coverage remained stable.
$PFE has been slapped with a fine of $107 million by the UK for overcharging its epilepsy drug.
President Trump's tweet suggesting cancellation of Air Force One contract with $BA citing high cost has made the headlines. Will it make any impact in the Street for Boeing since the aircraft is meant for the use of President of US?
For the past few quarters $LULU has had a consistent net revenue increase of around 16%, so expecting the same this time around too. Maybe more!!!